Although the AHNAK transcript levels was found to be similar in GBM compared to control brain samples (Figure 2D), we found a significantly lower level in GSCs when compared to the differentiated glioma cells (DGCs) (Figure 2D). This evidence concerns the gene AHNAK and central nervous system cancer.